BioTime, Inc. is a US-based biotechnology company that focuses on developing and manufacturing affordable research reagents and raw materials for biomedical researchers and diagnostic companies worldwide. Founded in 1990, the company's core technology platform is pluripotent cells, which have the potential to regenerate or replace affected cells and tissues in various age-related degenerative diseases and conditions. By providing high-quality immunoassays, recombinant proteins, and validated antibody reagents, BioTime aims to enable discovery and product innovation in the field of biomedicine.